卫宁健康
(300253)
| 流通市值：201.51亿 | | | 总市值：233.11亿 |
| 流通股本：19.12亿 | | | 总股本：22.12亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,913,315,732.46 | 1,223,742,976.83 | 494,492,405.71 | 3,163,424,802.81 |
| 营业收入 | 1,913,315,732.46 | 1,223,742,976.83 | 494,492,405.71 | 3,163,424,802.81 |
| 二、营业总成本 | 1,775,372,358.9 | 1,158,172,450.36 | 533,559,489.09 | 2,808,746,305.49 |
| 营业成本 | 1,128,086,329.35 | 717,727,313.69 | 327,810,492.51 | 1,739,817,519.41 |
| 税金及附加 | 14,583,932.94 | 10,067,015.13 | 4,149,071.41 | 29,649,081.25 |
| 销售费用 | 240,620,283.19 | 166,899,882.19 | 74,452,570.42 | 459,498,652.9 |
| 管理费用 | 140,458,898.95 | 97,842,079.98 | 42,797,598.54 | 195,398,788.09 |
| 研发费用 | 209,221,376.53 | 137,369,566.7 | 70,107,264.95 | 333,302,222.75 |
| 财务费用 | 42,401,537.94 | 28,266,592.67 | 14,242,491.26 | 51,080,041.09 |
| 其中:利息费用 | 50,453,808.49 | 33,538,244.16 | 16,793,005.96 | 64,051,540.73 |
| 其中:利息收入 | 8,626,552.12 | 6,144,582.72 | 2,673,719.24 | 13,590,811.58 |
| 加:公允价值变动收益 | 4,887,217.86 | 6,961,257.11 | 6,961,257.11 | -50,464,459.13 |
| 加:投资收益 | -30,010,311.4 | -20,894,459.16 | -16,385,826.8 | 29,498,207.38 |
| 资产处置收益 | 178,476.75 | 174,975.76 | 128,159.9 | -425,833.83 |
| 资产减值损失(新) | -64,330,256.79 | -77,389,416.55 | -1,195,178.41 | -136,734,803.21 |
| 信用减值损失(新) | -7,499,818.52 | -6,546,213.76 | 20,235,580.27 | -7,870,229.6 |
| 其他收益 | 83,237,076.67 | 49,456,737.59 | 27,020,618.39 | 152,749,631.11 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 124,405,758.13 | 17,333,407.46 | -2,302,472.92 | 341,431,010.04 |
| 加:营业外收入 | 32,354.79 | 7,257.09 | 6.29 | 233,232.75 |
| 减:营业外支出 | 545,382.11 | 225,981.69 | 17,613.16 | 917,040.02 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 123,892,730.81 | 17,114,682.86 | -2,320,079.79 | 340,747,202.77 |
| 减:所得税费用 | -13,551,055.98 | -5,099,392.55 | -8,814,529.83 | 23,131,711.85 |
| 六、净利润 | 137,443,786.79 | 22,214,075.41 | 6,494,450.04 | 317,615,490.92 |
| 持续经营净利润 | 137,443,786.79 | 22,214,075.41 | 6,494,450.04 | 317,615,490.92 |
| 归属于母公司股东的净利润 | 154,630,806.68 | 30,168,354.32 | 16,620,407.26 | 357,959,124.85 |
| 少数股东损益 | -17,187,019.89 | -7,954,278.91 | -10,125,957.22 | -40,343,633.93 |
| (一)基本每股收益 | 0.07 | 0.01 | 0.01 | 0.17 |
| (二)稀释每股收益 | 0.07 | 0.01 | 0.01 | 0.16 |
| 九、综合收益总额 | 137,443,786.79 | 22,214,075.41 | 6,494,450.04 | 317,615,490.92 |
| 归属于母公司股东的综合收益总额 | 154,630,806.68 | 30,168,354.32 | 16,620,407.26 | 357,959,124.85 |
| 归属于少数股东的综合收益总额 | -17,187,019.89 | -7,954,278.91 | -10,125,957.22 | -40,343,633.93 |
| 公告日期 | 2024-10-30 | 2024-08-29 | 2024-04-27 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |